Am. J. Respir. Crit. Care Med., Vol 155, No. 6, 06 1997, 1902-1907.
Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis
C Wojnarowski, I Eichler, C Gartner, M Gotz, S Renner, DY Koller and T Frischer
University Children's Hospital and the Children's Department, Wilhelminenspital, Vienna, Austria.
Colonization with Aspergillus fumigatus (Af) constitutes a common finding
in children with cystic fibrosis (CF). The relationship between
sensitization to Af and lung functon (LF) was studied in 118 patients with
CF (61 girls and 57 boys; mean age: 14.3 yr; SD: 7 yr). Mean follow up was
2.2 yr. On average, 8.1 (SD: 4.8) LF tests were performed per patient.
Measurement of total IgE and specific IgE antibodies to Af, and a skin
prick test (SPT) for Af, were done once a year. Thirty- one children (26%)
were sensitized to Af. On average, LF parameters were not significantly
different in Af-sensitized children than in nonsensitized children. Linear
regression analyses were performed, using the repeated measures design.
With adjustment for gender, age, height, and weight, sensitization to Af
was associated with lower values of FEV1 (beta = -0.209; p < 0.05) and
FEF(25-75) (beta = -0.356; p < 0.01). Analysis of different subgroups of
sensitization demonstrated the effect on LF only in Af-sensitized patients
with elevated total IgE levels, and not in Af-sensitized patients with
normal IgE levels. Furthermore, there was evidence for a more rapid decline
in LF for Af-sensitized patients with elevated total IgE levels than in
those with normal IgE levels. We conclude that sensitization to Af in the
presence of increased IgE values is associated with lower LF values in
children with CF.
This article has been cited by other articles:

|
 |

|
 |
 
R. Kraemer, N. Delosea, P. Ballinari, S. Gallati, and R. Crameri
Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
December 1, 2006;
174(11):
1211 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Conway, C. Etherington, D. G. Peckham, K. G. Brownlee, A. Whitehead, and H. Cunliffe
Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis
J. Antimicrob. Chemother.,
May 1, 2004;
53(5):
841 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Maiz, M. Cuevas, S. Quirce, J. F. Canon, A. Pacheco, A. Sousa, and H. Escobar
Serologic IgE Immune Responses Against Aspergillus fumigatus and Candida albicans in Patients With Cystic Fibrosis
Chest,
March 1, 2002;
121(3):
782 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. Lin, H.-J. Su, T.-R. Hsiue, C.-H. Lee, C.-W. Chen, and Y. L. Guo
Levels of House Dust Mite-Specific IgE and Cockroach-Specific IgE and Their Association With Lower Pulmonary Function in Taiwanese Children
Chest,
February 1, 2002;
121(2):
347 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marchand, C. Verellen-Dumoulin, M. Mairesse, L. Delaunois, P. Brancaleone, J.-F. Rahier, and O. Vandenplas
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis
Chest,
March 1, 2001;
119(3):
762 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.A. Kastelik, I. Aziz, A.E. Redington, and A.H. Morice
Allergic bronchopulmonary aspergillosis in cystic fibrosis
Eur. Respir. J.,
January 1, 2001;
17(1):
156 - 156.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. B. Nepomuceno, S. Esrig, and R. B. Moss
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: Role of Atopy and Response to Itraconazole
Chest,
February 1, 1999;
115(2):
364 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 American Thoracic Society
|
|
|